Becherer A - Search Results

1

Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type.

Hoffmann M, Kletter K, Diemling M, Becherer A, Pfeffel F, Petkov V, Chott A, Raderer M. Hoffmann M, et al. Among authors: becherer a. Ann Oncol. 1999 Oct;10(10):1185-9. doi: 10.1023/a:1008312726163. Ann Oncol. 1999. PMID: 10586335 Free article.

2

Imaging of cutaneous recurrence of gastric cancer with F-18 FDG positron emission tomography.

Hoffmann M, Oberhuber G, Kletter K, Becherer A, Raderer M. Hoffmann M, et al. Among authors: becherer a. Clin Nucl Med. 2002 Oct;27(10):731-2. doi: 10.1097/00003072-200210000-00012. Clin Nucl Med. 2002. PMID: 12352119 No abstract available.

3

FDG positron emission tomography in patients with systemic mastocytosis.

Zettinig G, Becherer A, Szabo M, Uffmann M, Dudczak R, Valent P, Kletter K. Zettinig G, et al. Among authors: becherer a. AJR Am J Roentgenol. 2002 Nov;179(5):1235-7. doi: 10.2214/ajr.179.5.1791235. AJR Am J Roentgenol. 2002. PMID: 12388504

4

18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma.

Hoffmann M, Kletter K, Becherer A, Jäger U, Chott A, Raderer M. Hoffmann M, et al. Among authors: becherer a. Oncology. 2003;64(4):336-40. doi: 10.1159/000070290. Oncology. 2003. PMID: 12759529

5

18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver.

Kurtaran A, Becherer A, Pfeffel F, Müller C, Traub T, Schmaljohann J, Kaserer K, Raderer M, Schima W, Dudczak R, Kletter K, Virgolini I. Kurtaran A, et al. Among authors: becherer a. Liver. 2000 Dec;20(6):487-90. doi: 10.1034/j.1600-0676.2000.020006487.x. Liver. 2000. PMID: 11169064

6

Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma.

De Santis M, Bokemeyer C, Becherer A, Stoiber F, Oechsle K, Kletter K, Dohmen BM, Dittrich C, Pont J. De Santis M, et al. Among authors: becherer a. J Clin Oncol. 2001 Sep 1;19(17):3740-4. doi: 10.1200/JCO.2001.19.17.3740. J Clin Oncol. 2001. PMID: 11533096 Clinical Trial.

7

Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.

Becherer A, Mitterbauer M, Jaeger U, Kalhs P, Greinix HT, Karanikas G, Pötzi C, Raderer M, Dudczak R, Kletter K. Becherer A, et al. Leukemia. 2002 Feb;16(2):260-7. doi: 10.1038/sj.leu.2402342. Leukemia. 2002. PMID: 11840293

8

Prognostic value of FDG-PET in malignant lymphoma.

Becherer A, Jaeger U, Szabo M, Kletter K. Becherer A, et al. Q J Nucl Med. 2003 Mar;47(1):14-21. Q J Nucl Med. 2003. PMID: 12714950 Free article. Review.

9

18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading.

Wöhrer S, Jaeger U, Kletter K, Becherer A, Hauswirth A, Turetschek K, Raderer M, Hoffmann M. Wöhrer S, et al. Among authors: becherer a. Ann Oncol. 2006 May;17(5):780-4. doi: 10.1093/annonc/mdl014. Epub 2006 Feb 23. Ann Oncol. 2006. PMID: 16497824 Free article.

10

18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference.

Hoffmann M, Wöhrer S, Becherer A, Chott A, Streubel B, Kletter K, Raderer M. Hoffmann M, et al. Among authors: becherer a. Ann Oncol. 2006 Dec;17(12):1761-5. doi: 10.1093/annonc/mdl295. Epub 2006 Sep 15. Ann Oncol. 2006. PMID: 16980600 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters